Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.

Woei-A-Jin FJSH, Van Nieuwenhuyse T, van Erp NP, Beuselinck B, Stroobants S, Moes DJAR, Osanto S, Spriet I.

J Clin Oncol. 2018 Sep 6:JCO2018793182. doi: 10.1200/JCO.2018.79.3182. [Epub ahead of print] No abstract available.

PMID:
30188790
2.

Cabozantinib in the treatment of advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy: clinical trial evidence and experience.

Osanto S, van der Hulle T.

Ther Adv Urol. 2018 Jan 9;10(3):109-123. doi: 10.1177/1756287217748867. eCollection 2018 Mar. Review.

3.

CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.

Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, Burgmans MC, Farina-Sarasqueta A, Snaar-Jagalska EB, Stroka DM, Terracciano L, van Hoek B, Schaapherder AF, Osanto S, Thalmann GN, Verspaget HW, Coenraad MJ, Kruithof-de Julio M.

J Pathol. 2018 Jul;245(3):297-310. doi: 10.1002/path.5083. Epub 2018 May 9.

PMID:
29604056
4.

International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.

van Leeuwen M, Kieffer JM, Efficace F, Fosså SD, Bolla M, Collette L, Colombel M, De Giorgi U, Holzner B, van de Poll-Franse LV, van Poppel H, White J, de Wit R, Osanto S, Aaronson NK; European Organisation for Research and Treatment of Cancer Quality of Life Group; Genito-Urinary Cancers Group and Radiation Oncology Group; and the NCRN Testis Clinical Studies Group.

Health Qual Life Outcomes. 2017 May 11;15(1):97. doi: 10.1186/s12955-017-0670-4.

5.

Fertility preservation counselling in Dutch Oncology Practice: Are nurses ready to assist physicians?

Krouwel EM, Nicolai MPJ, van Steijn-van Tol AQMJ, Putter H, Osanto S, Pelger RCM, Elzevier HW.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12614. Epub 2016 Dec 27.

PMID:
28026055
6.

Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?

Woei-A-Jin FJ, Tesselaar ME, Garcia Rodriguez P, Romijn FP, Bertina RM, Osanto S.

Br J Cancer. 2016 Jul 26;115(3):332-8. doi: 10.1038/bjc.2016.170. Epub 2016 Jul 12.

7.

Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study.

Aben KK, Osanto S, Hulsbergen-van de Kaa CA, Soetekouw PM, Stemkens D, Bex A.

World J Urol. 2016 Aug;34(8):1053-60. doi: 10.1007/s00345-016-1841-3. Epub 2016 May 13.

8.

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.

Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators.

N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25.

9.

Addressing changed sexual functioning in cancer patients: A cross-sectional survey among Dutch oncology nurses.

Krouwel EM, Nicolai MP, van Steijn-van Tol AQ, Putter H, Osanto S, Pelger RC, Elzevier HW.

Eur J Oncol Nurs. 2015 Dec;19(6):707-15. doi: 10.1016/j.ejon.2015.05.005. Epub 2015 Jun 6.

PMID:
26051072
10.

Changes in bone mineral density in newly diagnosed testicular cancer patients after anticancer treatment.

Willemse PM, Hamdy NA, de Kam ML, Burggraaf J, Osanto S.

J Clin Endocrinol Metab. 2014 Nov;99(11):4101-8. doi: 10.1210/jc.2014-1722. Epub 2014 Aug 13.

PMID:
25119312
11.

Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients.

Broeyer FJ, Osanto S, Suzuki J, de Jongh F, van Slooten H, Tanis BC, Bruning T, Bax JJ, Ritsema van Eck HJ, de Kam ML, Cohen AF, Mituzhima Y, Burggraaf J.

Br J Clin Pharmacol. 2014 Nov;78(5):950-60. doi: 10.1111/bcp.12429.

12.

Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities.

van Leeuwen M, Efficace F, Fosså SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S, Aaronson NK; European Organisation for Research and Treatment of Cancer Quality of Life Group; Genito-Urinary Cancers Group; Radiation Oncology Group.

Eur J Cancer. 2014 Jul;50(11):1957-63. doi: 10.1016/j.ejca.2014.04.018. Epub 2014 May 9.

PMID:
24820932
13.

Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.

Woei-A-Jin FJ, van der Starre WE, Tesselaar ME, Garcia Rodriguez P, van Nieuwkoop C, Bertina RM, van Dissel JT, Osanto S.

Thromb Res. 2014 May;133(5):799-803. doi: 10.1016/j.thromres.2014.03.007. Epub 2014 Mar 6.

PMID:
24657035
14.

Cryo-electron microscopy of extracellular vesicles in fresh plasma.

Yuana Y, Koning RI, Kuil ME, Rensen PC, Koster AJ, Bertina RM, Osanto S.

J Extracell Vesicles. 2013 Dec 31;2. doi: 10.3402/jev.v2i0.21494. eCollection 2013 Dec 31.

15.

Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

van Bergen CA, Verdegaal EM, Honders MW, Hoogstraten C, Steijn-van Tol AQ, de Quartel L, de Jong J, Meyering M, Falkenburg JH, Griffioen M, Osanto S.

PLoS One. 2014 Jan 15;9(1):e85198. doi: 10.1371/journal.pone.0085198. eCollection 2014.

16.

Reply: Comment on 'Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'.

van Schinkel LD, Willemse PM, van der Meer RW, Burggraaf J, van Elderen SG, Smit JW, de Roos A, Osanto S, Lamb HJ.

Br J Cancer. 2014 Jan 7;110(1):265. doi: 10.1038/bjc.2013.704. Epub 2013 Nov 7. No abstract available.

17.

Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention.

Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AA, Cannegieter SC, Jukema JW, Umans VA, Schalij MJ, van Boven AJ.

Am J Cardiol. 2013 Dec 15;112(12):1867-72. doi: 10.1016/j.amjcard.2013.08.019. Epub 2013 Sep 21.

PMID:
24063839
18.

Reply: 'Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.

Willemse PM, Burggraaf J, Hamdy NA, Osanto S.

Br J Cancer. 2013 Oct 29;109(9):2503-4. doi: 10.1038/bjc.2013.567. Epub 2013 Sep 17. No abstract available.

19.

Tasquinimod: a novel drug in advanced prostate cancer.

Osanto S, van Poppel H, Burggraaf J.

Future Oncol. 2013 Sep;9(9):1271-81. doi: 10.2217/fon.13.136.

PMID:
23980674
20.

Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Van Poppel H, Watkin NA, Osanto S, Moonen L, Horwich A, Kataja V; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi115-24. doi: 10.1093/annonc/mdt286. Epub 2013 Aug 23. No abstract available.

PMID:
23975666

Supplemental Content

Loading ...
Support Center